Eastgate Biotech logo

ETBI - Eastgate Biotech Share Price

$0.006 0.0  0.0%

Last Trade - 04/12/20

Micro Cap
Market Cap £3.20m
Enterprise Value £5.48m
Revenue £102k
Position in Universe th / 6444
Unlock ETBI Revenue
Relative Strength (%)
1m +41.6%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -80.0%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2011 2012 2013 2014 2015 2016 2017E 2018E CAGR / Avg
0.000 0.000 0.000 0.000 0.13 0.000
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 30 September 2017,Eastgate Biotech Corp revenues increased from $0K to $138K.Net loss applicable to common stockholders increased 35% to$3.2M. Revenues reflect an increase in demand for theCompany's products and services due to favorable marketconditions. Higher net loss reflects General andadministrative increase of 65% to $2.5M (expense), Interestexpenses increase from $117K to $255K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


ETBI Revenue Unlock ETBI Revenue

Net Income

ETBI Net Income Unlock ETBI Revenue

Normalised EPS

ETBI Normalised EPS Unlock ETBI Revenue

PE Ratio Range

ETBI PE Ratio Range Unlock ETBI Revenue

Dividend Yield Range

ETBI Dividend Yield Range Unlock ETBI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ETBI EPS Forecasts Unlock ETBI Revenue
Profile Summary

Eastgate Biotech Corp. is a pharmaceutical company. The Company is primarily engaged in the development of formulations of natural compounds and pharmaceutical products. The Company produces and distributes healthy nutraceuticals that are based on natural therapies and absorbed naturally by the body. The Company offers EGP-1214, a compressed tablet containing human recombinant insulin that is designed for sublingual administration. It offers a range of products, such as E-Drops, which is used to combat urinary and vaginal tract infections; Essential D, which is an enhanced Vitamin D3, working to improve the body's digestive, cardiovascular, and immune systems; Puralen, is an all-natural herbal cleanse of colon and the urinary tract; GluCora, which prevents fat deposition; VCleanzz, which is an antibacterial wash for fruits and vegetables; Cleanezze, which is a natural hand sanitizer, and Warts X, which is a natural herbal product that treats warts.

Last Annual December 31st, 2016
Last Interim September 30th, 2017
Incorporated September 8, 1999
Public Since January 16, 2014
No. of Shareholders: n/a
No. of Employees: n/a
Sector Financials
Industry Collective Investments
Exchange Pink Sheets on Nasdaq
Shares in Issue 717,257,377
Free Float (0.0%)
Eligible for
ETBI Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ETBI
Upcoming Events for ETBI
Frequently Asked Questions for Eastgate Biotech
What is the Eastgate Biotech share price?

As of 04/12/20, shares in Eastgate Biotech are trading at $0.006, giving the company a market capitalisation of £3.20m. This share price information is delayed by 15 minutes.

How has the Eastgate Biotech share price performed this year?

Shares in Eastgate Biotech are currently trading at $0.006 and the price has moved by -24.05% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Eastgate Biotech price has moved by -33.84% over the past year.

What are the analyst and broker recommendations for Eastgate Biotech?

There are no analysts currently covering Eastgate Biotech.

When will Eastgate Biotech next release its financial results?

Eastgate Biotech is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2018-09-30
What is the Eastgate Biotech dividend yield?

Eastgate Biotech does not currently pay a dividend.

Does Eastgate Biotech pay a dividend?

Eastgate Biotech does not currently pay a dividend.

When does Eastgate Biotech next pay dividends?

Eastgate Biotech does not currently pay a dividend.

How do I buy Eastgate Biotech shares?

To buy shares in Eastgate Biotech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Eastgate Biotech?

Shares in Eastgate Biotech are currently trading at $0.006, giving the company a market capitalisation of £3.20m.

Where are Eastgate Biotech shares listed? Where are Eastgate Biotech shares listed?

Here are the trading details for Eastgate Biotech:

Country of listing: United States
Exchange: PNK
Ticker Symbol: ETBI
What kind of share is Eastgate Biotech?

We were not able to load our ranking data for Eastgate Biotech

Is there a Eastgate Biotech share price forecast 2020?

We were not able to load any forecast data for Eastgate Biotech.

How can I tell whether the Eastgate Biotech share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Eastgate Biotech. Over the past six months, the relative strength of its shares against the market has been 0.247k%. At the current price of $0.006, shares in Eastgate Biotech are trading at -14.56% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Eastgate Biotech PE Ratio?

We were not able to find PE ratio data for Eastgate Biotech.

Who are the key directors of Eastgate Biotech?

Eastgate Biotech's management team is headed by:

Anna Gluskin - CEO
Rose Perri - PRE
Bill Abajian - COO
Who are the major shareholders of Eastgate Biotech?

Here are the top five shareholders of Eastgate Biotech based on the size of their shareholding:

Associated Investment Management, LLC Investment Advisor
Percentage owned: 0.04% (289k shares)
Similar to ETBI
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.